Schedule 13D ownership disclosure

SPRUCE BIOSCIENCES INC

Common Stock, par value $0.001 per share · CUSIP: 85209E109

Event date: 2025-01-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RiverVest Venture Fund III, L.P.Reported CIK 0001601559

    Shares: 720,656.00 · Class: 0.2%

  • RiverVest Venture Fund III (Ohio), L.P.Reported CIK 0001636686

    Shares: 38,251.00 · Class: 0.1%

  • RiverVest Venture Partners III (Ohio), LLCReported CIK 0001752269

    Shares: 38,251.00 · Class: 0.1%

  • RiverVest Venture Partners III, L.P.Reported CIK 0001752268

    Shares: 758,907.00 · Class: 0.2%

  • RiverVest Venture Partners III, LLCReported CIK 0001752405

    Shares: 758,907.00 · Class: 0.2%

  • RiverVest Venture Fund IV, L.P.Reported CIK 0001725443

    Shares: 1,000,614.00 · Class: 2.4%

  • RiverVest Venture Partners IV, L.P.

    Shares: 1,000,614.00 · Class: 2.4%

  • RiverVest Venture Partners IV, LLC

    Shares: 1,000,614.00 · Class: 2.4%

  • John P. McKearn, Ph.D.Reported CIK 0001240120

    Shares: 1,759,521.00 · Class: 4.2%

  • Jay SchmelterReported CIK 0001435248

    Shares: 1,759,521.00 · Class: 4.2%

  • Thomas C. MelzerReported CIK 0001611651

    Shares: 758,907.00 · Class: 0.2%

  • Niall O'Donnell, Ph.D.Reported CIK 0001780235

    Shares: 1,000,614.00 · Class: 2.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-002369
Form type
SCHEDULE 13D/A
Filer
RiverVest Venture Fund III, L.P.
CIK
CIK 1601559
Filed
Jan 10, 2025
Reporting period
Jan 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub